LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 76 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $216,000 | -47.8% | 51,500 | -51.1% | 0.12% | +134.7% |
Q4 2019 | $414,000 | -67.2% | 105,400 | -26.6% | 0.05% | -69.8% |
Q3 2019 | $1,263,000 | -40.7% | 143,600 | -37.7% | 0.16% | +9.5% |
Q2 2019 | $2,130,000 | -13.9% | 230,364 | -40.2% | 0.15% | +28.7% |
Q1 2019 | $2,475,000 | +113.5% | 384,917 | +213.0% | 0.12% | +43.8% |
Q4 2018 | $1,159,000 | +286.3% | 122,995 | +342.4% | 0.08% | +70.2% |
Q1 2014 | $300,000 | – | 27,800 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
Summit Global Investments | 48,500 | $208,000 | 0.01% |